IBIO insider filings
iBio, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-08-04. Screen IBIO transaction legs live →
Insider transaction summary — last 90 days
2026-07-10 to 2026-10-08, from the filings listed below: 1 insider filing (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 1.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Carr Molly — Chief Medical Officer | 1 | — | — | 1 |
Recent insider filings — iBio, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-04 | 4 | Carr Molly — Chief Medical Officer | Grant/award (A): 430,000 (derivative) @ $0 | EDGAR |
| 2026-05-19 | 4 | Stoner Elizabeth — Director | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2026-03-27 | 4 | Banjak Marc — Chief Legal Officer | Purchase (P): 12,500 @ $1.64 · Purchase (P): 1,434 @ $1.76 | EDGAR |
| 2026-03-23 | 4 | Duran Felipe — Chief Financial Officer | Purchase (P): 24,835 @ $2.02 | EDGAR |
| 2026-03-23 | 4 | Brenner Martin — See Remarks, Director | Purchase (P): 12,336 @ $2.02 | EDGAR |
| 2026-01-30 | 4 | Banjak Marc — Chief Legal Officer | Grant/award (A): 146,000 (derivative) @ $0 | EDGAR |
| 2026-01-30 | 4 | Duran Felipe — Chief Financial Officer | Grant/award (A): 179,000 (derivative) @ $0 | EDGAR |
| 2026-01-30 | 4 | Brenner Martin — See Remarks, Director | Grant/award (A): 479,000 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Schimmelpennink Evert B. — Director | Grant/award (A): 13,500 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Sender Gary — Director | Grant/award (A): 13,500 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Kropotova Alexandra — Director | Grant/award (A): 13,500 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Parada Antonio Bernardino Guimaraes — Director | Grant/award (A): 13,500 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Clark William D — Director | Grant/award (A): 13,500 (derivative) @ $0 | EDGAR |
| 2025-11-24 | 4 | Arkowitz David — Director | Grant/award (A): 13,500 (derivative) @ $0 | EDGAR |
| 2025-10-22 | 4 | Duran Felipe — Chief Financial Officer | Grant/award (A): 75,000 (derivative) @ $0 | EDGAR |
| 2025-10-22 | 4 | Banjak Marc — Chief Legal Officer | Grant/award (A): 55,000 (derivative) @ $0 | EDGAR |
| 2025-10-22 | 4 | Brenner Martin — See Remarks, Director | Grant/award (A): 180,000 (derivative) @ $0 | EDGAR |
| 2025-02-24 | 4 | Banjak Marc — Chief Legal Officer | Grant/award (A): 71,000 (derivative) @ $0 | EDGAR |
| 2025-02-24 | 4 | Duran Felipe — Chief Financial Officer | Grant/award (A): 84,700 (derivative) @ $0 | EDGAR |
| 2025-02-24 | 4 | Brenner Martin — See Remarks, Director | Grant/award (A): 230,700 (derivative) @ $0 | EDGAR |
| 2025-01-13 | 4 | Duran Felipe — Chief Financial Officer | Purchase (P): 9,191 @ $2.72 | EDGAR |
| 2025-01-13 | 4 | Brenner Martin — See Remarks, Director | Purchase (P): 9,191 @ $2.72 | EDGAR |
| 2025-01-13 | 4 | Banjak Marc — Chief Legal Officer | Purchase (P): 9,191 @ $2.72 | EDGAR |
| 2025-01-13 | 4 | Clark William D — Director | Purchase (P): 1,838 @ $2.72 | EDGAR |
| 2025-01-13 | 4 | Parada Antonio Bernardino Guimaraes — Director | Purchase (P): 183,823 @ $2.72 | EDGAR |
| 2025-01-13 | 4 | Sender Gary — Director | Purchase (P): 9,191 @ $2.72 | EDGAR |
| 2025-01-13 | 4 | Arkowitz David — Director | Purchase (P): 18,382 @ $2.72 | EDGAR |
| 2024-12-09 | 4 | Parada Antonio Bernardino Guimaraes — Director | Grant/award (A): 12,600 (derivative) @ $0 | EDGAR |
| 2024-11-25 | 4 | Sender Gary — Director | Grant/award (A): 18,900 (derivative) @ $0 | EDGAR |
| 2024-11-25 | 4 | Schimmelpennink Evert B. — Director | Grant/award (A): 18,900 (derivative) @ $0 | EDGAR |
| 2024-11-25 | 4 | Kropotova Alexandra — Director | Grant/award (A): 18,900 (derivative) @ $0 | EDGAR |
| 2024-11-25 | 4 | Clark William D — Director | Grant/award (A): 18,900 (derivative) @ $0 | EDGAR |
| 2024-11-25 | 4 | Arkowitz David — Director | Grant/award (A): 12,600 (derivative) @ $0 | EDGAR |
| 2024-05-13 | 4 | Brenner Martin — See Remarks | Grant/award (A): 147,300 (derivative) @ $0 · Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
| 2024-05-13 | 4 | Duran Felipe — Chief Financial Officer | Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2024-04-26 | 4 | Duran Felipe — Chief Financial Officer | Grant/award (A): 35,800 (derivative) @ $0 | EDGAR |
| 2023-11-03 | 4 | Brenner Martin — See Remarks | Sale (S): 4,881 @ $0.27 | EDGAR |
| 2023-10-05 | 4 | Brenner Martin — See Remarks | Sale (S): 5,267 @ $0.30 | EDGAR |
| 2023-10-03 | 4 | Brenner Martin — See Remarks | Sale (S): 4,215 @ $0.31 | EDGAR |
| 2023-08-30 | 4 | Brenner Martin — See Remarks | Sale (S): 5,011 @ $0.31 | EDGAR |
| 2023-08-24 | 4 | Duran Felipe — Chief Financial Officer | Grant/award (A): 60,000 (derivative) @ $0 | EDGAR |
| 2023-08-24 | 4 | Brenner Martin — See Remarks | Grant/award (A): 120,000 (derivative) @ $0 | EDGAR |
| 2023-07-28 | 4 | Brenner Martin — See Remarks | Sale (S): 4,480 @ $0.51 · Sale (S): 35 @ $0.51 | EDGAR |
| 2023-07-13 | 4 | Brenner Martin — See Remarks | Sale (S): 47,020 @ $0.59 | EDGAR |
| 2023-06-27 | 4 | Brenner Martin — See Remarks | Disposition to issuer (D): 75,833 @ $0 · Grant/award (A): 75,833 @ $0 | EDGAR |
| 2023-06-22 | 4 | Brenner Martin — See Remarks | Sale (S): 3,859 @ $0.68 · Sale (S): 225 @ $0.69 · Sale (S): 100 @ $0.68 | EDGAR |
| 2023-05-24 | 4 | Brenner Martin — See Remarks | Sale (S): 4,158 @ $0.94 · Sale (S): 24 @ $0.94 | EDGAR |
| 2023-04-24 | 4 | Brenner Martin — See Remarks | Sale (S): 4,382 @ $1.20 | EDGAR |
| 2023-04-03 | 4 | Brenner Martin — See Remarks | Grant/award (A): 50,000 @ $0 | EDGAR |
| 2023-04-03 | 4 | Duran Felipe — Chief Financial Officer | Grant/award (A): 37,500 @ $0 | EDGAR |
Recent 8-K events — iBio, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-14 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-28 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-04 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-17 | 8-K | ? 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-01 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-08 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-17 | 8-K/A | 8.01 — Other Events | EDGAR |
| 2026-04-08 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-09 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=IBIO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →